Pleural effusion caused by plasma cell involvement in multiple myeloma has
been reported unfrequently, and has Been described at a frequency below 1%
of multiple myeloma. In this study, we report an observation with pleural e
ffusion as first symptom of multiple myeloma. The analysis of the pleural l
iquid showed plasma cells with a monoclonal IgG Kappa immunoglobulin. In ad
dition, there uns a bone marrow infiltration by plasma cells, a serum monoc
lonal immunoglobulin of the same type and osteolytic lesions. Our patient h
as received one course of chemotherapy with: vincristine, melphalan, cyclop
hosphamide and prednisone. The patient did not respond to the therapy and d
ied one month later: Pleural effusion seems to he an expression of agressiv
e myeloma. Survival exceeds rarely 4 months.